Avaliação das motivações para o consumo de tabaco em pacientes com câncer de cabeça e pescoço em diferentes fases do tratamento oncológico

• Autor(a) principal: Antunes, Ana Daniela Spínola da Silva [UNESP]
• Data de Publicação: 2018
• Tipo de documento: Trabalho de conclusão de curso
• Idioma: por
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://hdl.handle.net/11449/204009; http://www.athena.biblioteca.unesp.br/exlibris/bd/capelo/2019-05-29/000914031.pdf
• topic: Carcinoma de células escamosas; Neoplasias de cabeça e pescoço; Abandono do uso de tabaco; Tabagismo; Motivação; Carcinoma, Squamous Cell

Smoking is the main risk factor for head and neck cancer. Around 90% of patients with head and neck squamous cell carcinoma (SCC) are smokers at the moment of diagnosis. Part of these patients do not abandon the addiction, even with cancer diagnosis and treatment, which might increase the risk of tumor recurrence and influence the treatment negatively. The objective of this study was to evaluate tobacco consumption changes and its motivations in head and neck SCC patients in different phases of diagnosis and oncological treatment. The research included 70 smoker patients with definite diagnosis of head and neck SCC treated at the Centro de Oncologia Bucal - COB (Mouth Oncology Center) at FOA/UNESP. All the patients were submitted to an interview using a semi-structured questionnaire with open questions about their profile and smoking, as well as their motivations. The demographic, clinical, and pathological data was obtained through their clinical charts. The descriptive dada from the open questions, including motivation to change tobacco consumption, were evaluated through the Discourse of the Collective Subject Methodology. The results showed that 37% of patients with head and neck SCC continued smoking even after the end of oncological treatment. Tobacco dependence and the need to calm down were the main factors reported by patients as motivation keep addicted after the cancer diagnosis and treatment. Among the patients who stopped or decreased tobacco consumption during any phase of the diagnosis or treatment, the fear of cancer recurrence was paramount to abandon the addiction. The present results show the need to establish diagnosis strategies and support to tobacco dependence during the different stages of head and neck cancer treatment